354 related articles for article (PubMed ID: 31195398)
1. miR-130b Promotes Sunitinib Resistance through Regulation of PTEN in Renal Cell Carcinoma.
Sekino Y; Sakamoto N; Sentani K; Oue N; Teishima J; Matsubara A; Yasui W
Oncology; 2019; 97(3):164-172. PubMed ID: 31195398
[TBL] [Abstract][Full Text] [Related]
2. MiR-130b plays an oncogenic role by repressing PTEN expression in esophageal squamous cell carcinoma cells.
Yu T; Cao R; Li S; Fu M; Ren L; Chen W; Zhu H; Zhan Q; Shi R
BMC Cancer; 2015 Jan; 15():29. PubMed ID: 25637514
[TBL] [Abstract][Full Text] [Related]
3. Depletion of lncRNA MALAT1 inhibited sunitinib resistance through regulating miR-362-3p-mediated G3BP1 in renal cell carcinoma.
Wang Z; Chang X; Zhu G; Gao X; Chang L
Cell Cycle; 2020 Aug; 19(16):2054-2062. PubMed ID: 32663095
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor PDCD4 and promotes cell transformation, proliferation, and metastasis in renal cell carcinoma.
Li X; Xin S; He Z; Che X; Wang J; Xiao X; Chen J; Song X
Cell Physiol Biochem; 2014; 33(6):1631-42. PubMed ID: 24902663
[TBL] [Abstract][Full Text] [Related]
5. PTEN Is Involved in Sunitinib and Sorafenib Resistance in Renal Cell Carcinoma.
Sekino Y; Hagura T; Han X; Babasaki T; Goto K; Inoue S; Hayashi T; Teishima J; Shigeta M; Taniyama D; Kuraoka K; Sentani K; Yasui W; Matsubara A
Anticancer Res; 2020 Apr; 40(4):1943-1951. PubMed ID: 32234883
[TBL] [Abstract][Full Text] [Related]
6. Metformin-Derived Growth Inhibition in Renal Cell Carcinoma Depends on miR-21-Mediated PTEN Expression.
Kalogirou C; Schäfer D; Krebs M; Kurz F; Schneider A; Riedmiller H; Kneitz B; Vergho D
Urol Int; 2016; 96(1):106-15. PubMed ID: 26496641
[TBL] [Abstract][Full Text] [Related]
7. Suppression of microRNA-130b inhibits glioma cell proliferation and invasion, and induces apoptosis by PTEN/AKT signaling.
Gu JJ; Fan KC; Zhang JH; Chen HJ; Wang SS
Int J Mol Med; 2018 Jan; 41(1):284-292. PubMed ID: 29115407
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-451 regulates chemoresistance in renal cell carcinoma by targeting ATF-2 gene.
Sun X; Lou L; Zhong K; Wan L
Exp Biol Med (Maywood); 2017 Jun; 242(12):1299-1305. PubMed ID: 28429654
[TBL] [Abstract][Full Text] [Related]
9. miR-96-5p targets PTEN to mediate sunitinib resistance in clear cell renal cell carcinoma.
Park SE; Kim W; Hong JY; Kang D; Park S; Suh J; You D; Park YY; Suh N; Hwang JJ; Kim CS
Sci Rep; 2022 Mar; 12(1):3537. PubMed ID: 35241735
[TBL] [Abstract][Full Text] [Related]
10. Circular RNA circSNX6 promotes sunitinib resistance in renal cell carcinoma through the miR-1184/GPCPD1/ lysophosphatidic acid axis.
Huang KB; Pan YH; Shu GN; Yao HH; Liu X; Zhou M; Wei JH; Chen ZH; Lu J; Feng ZH; Chen W; Han H; Zheng ZS; Luo JH; Zhang JX
Cancer Lett; 2021 Dec; 523():121-134. PubMed ID: 34626691
[TBL] [Abstract][Full Text] [Related]
11. Identification of MicroRNAs Involved in Resistance to Sunitinib in Renal Cell Carcinoma Cells.
Yamaguchi N; Osaki M; Onuma K; Yumioka T; Iwamoto H; Sejima T; Kugoh H; Takenaka A; Okada F
Anticancer Res; 2017 Jun; 37(6):2985-2992. PubMed ID: 28551636
[TBL] [Abstract][Full Text] [Related]
12. Uc.416 + A promotes epithelial-to-mesenchymal transition through miR-153 in renal cell carcinoma.
Sekino Y; Sakamoto N; Goto K; Honma R; Shigematsu Y; Quoc TP; Sentani K; Oue N; Teishima J; Kawakami F; Karam JA; Sircar K; Matsubara A; Yasui W
BMC Cancer; 2018 Oct; 18(1):952. PubMed ID: 30286729
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-200b is downregulated and suppresses metastasis by targeting LAMA4 in renal cell carcinoma.
Li Y; Guan B; Liu J; Zhang Z; He S; Zhan Y; Su B; Han H; Zhang X; Wang B; Li X; Zhou L; Zhao W
EBioMedicine; 2019 Jun; 44():439-451. PubMed ID: 31130475
[TBL] [Abstract][Full Text] [Related]
14. Mechanism and function of decreased FOXO1 in renal cell carcinoma.
Zhou L; Yin B; Liu Y; Hong Y; Zhang C; Fan J
J Surg Oncol; 2012 Jun; 105(8):841-7. PubMed ID: 22213032
[TBL] [Abstract][Full Text] [Related]
15. miR‑205 suppresses cell proliferation, invasion, and metastasis via regulation of the PTEN/AKT pathway in renal cell carcinoma.
Wang H; Chen B; Duan B; Zheng J; Wu X
Mol Med Rep; 2016 Oct; 14(4):3343-9. PubMed ID: 27498834
[TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA SNHG12 promotes tumour progression and sunitinib resistance by upregulating CDCA3 in renal cell carcinoma.
Liu Y; Cheng G; Huang Z; Bao L; Liu J; Wang C; Xiong Z; Zhou L; Xu T; Liu D; Yang H; Chen K; Zhang X
Cell Death Dis; 2020 Jul; 11(7):515. PubMed ID: 32641718
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-130b targets PTEN to mediate drug resistance and proliferation of breast cancer cells via the PI3K/Akt signaling pathway.
Miao Y; Zheng W; Li N; Su Z; Zhao L; Zhou H; Jia L
Sci Rep; 2017 Feb; 7():41942. PubMed ID: 28165066
[TBL] [Abstract][Full Text] [Related]
18. DNA methylation-regulated QPCT promotes sunitinib resistance by increasing HRAS stability in renal cell carcinoma.
Zhao T; Bao Y; Gan X; Wang J; Chen Q; Dai Z; Liu B; Wang A; Sun S; Yang F; Wang L
Theranostics; 2019; 9(21):6175-6190. PubMed ID: 31534544
[No Abstract] [Full Text] [Related]
19. Y-box binding protein-1 is crucial in acquired drug resistance development in metastatic clear-cell renal cell carcinoma.
D'Costa NM; Lowerison MR; Raven PA; Tan Z; Roberts ME; Shrestha R; Urban MW; Monjaras-Avila CU; Oo HZ; Hurtado-Coll A; Chavez-Munoz C; So AI
J Exp Clin Cancer Res; 2020 Feb; 39(1):33. PubMed ID: 32041631
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA DLX6-AS1 promotes renal cell carcinoma progression via miR-26a/PTEN axis.
Zeng X; Hu Z; Ke X; Tang H; Wu B; Wei X; Liu Z
Cell Cycle; 2017; 16(22):2212-2219. PubMed ID: 28881158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
